首页 产品目录 全部产品 水合氧化氢氧化(4-((5-((3,4-二羟基-6-(羟甲基)-5-((3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-3,4-二羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)-2,3,5,6-四羟基己酸根)铁(III)

水合氧化氢氧化(4-((5-((3,4-二羟基-6-(羟甲基)-5-((3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-3,4-二羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)-2,3,5,6-四羟基己酸根)铁(III)

Update to CAS 53858-86-9

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

9007-72-1

中文名称

水合氧化氢氧化(4-((5-((3,4-二羟基-6-(羟甲基)-5-((3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-3,4-二羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)-2,3,5,6-四羟基己酸根)铁(III)

英文名称

Update to CAS 53858-86-9

别名

Ferinject;Ferric carboxymaltose;Injectafer;Iron Dextri-Maltose;Ferric Carboxymaltos;Ferric carboxymahose;Injectafer USP/EP/BP;Ferric Carboxymaltose Injectafer

标准英文名

Ferric hydroxide polymaltose complex

分子式

N/A

SMILES

Ferric hydroxide polymaltose complex

用途

Ferric carboxymaltose is a novel intravenous iron preparation used as an effective parenteral iron supplement. It features a core-shell structure consisting of a polynuclear ferric oxyhydroxide (β-FeOOH) core surrounded by a carbohydrate shell (oxidized maltodextrin, also known as carboxymaltose), which stabilizes iron and controls its release, thereby preventing toxic oxidative stress caused by transiently high serum iron levels and saturation of transferrin and ferritin. With a high iron content (24–32% by weight; 47.5–52.5 mg/mL in solution), it allows rapid administration of 500–1500 mg of iron over 15 minutes, requires fewer doses, and demonstrates excellent iron-repletion efficacy, significantly improving patient compliance.

安全信息

评论 0
我是晶智Agent,
您的化学小助手